(110) identified microRNA-23a-3p as a key tumor-suppressor in mucosal melanoma, inhibiting mucosal melanoma progression by targeting adenylate cyclase 1 (ADCY1) and thereby inhibiting cAMP and MAPK signaling (110). Here, ADCY1 is linked to melanoma.